The sequence of drug development
Why does a drug therapy take so long to find? Hear from PKD Foundation Chief Scientific Officer David Baron, Ph.D. as he uses his decades of experience in drug development...
Understanding your lab results
Find out what lab tests are important to kidney patients, what constitutes normal and when your health team needs to take action. Originally aired: April 2013...
What is PKD?
PKD affects thousands in the United States and millions worldwide – and yet, many people have never heard of it. Learn basic facts about what PKD is, how it impacts...
Clinical studies: Patient participation is key in developing treatments
We believe empowered patients are the key to accelerating the development of a robust treatment pipeline. Without participation in research, medical breakthroughs cannot happen and new therapies cannot be approved...
Vasopressin: What it is and how it’s involved with PKD
In our first Webinar Wednesday presentation, PKD Foundation Chief Scientific Officer, David Baron, Ph.D., discusses vasopressin: what it is and how it is involved with polycystic kidney disease. He also...
